BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3226033)

  • 1. [A case of Mycobacterium kansasii lung infection developed after treatment of Mycobacterium gordonae lung infection].
    Umeki S; Okamoto Y; Hara Y
    Kekkaku; 1988 Dec; 63(12):785-90. PubMed ID: 3226033
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to chemotherapy of pulmonary infection due to mycobacterium kansasii.
    Harris GD; Johnason WG; Nicholson D
    Bull Int Union Tuberc; 1976; 51(1):275-8. PubMed ID: 1030296
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary disease due to Mycobacterium xenopi. Report of two cases.
    Bogaerts Y; Elinck W; van Renterghem D; Pauwels R; van der Straeten M
    Eur J Respir Dis; 1982 Jul; 63(4):298-304. PubMed ID: 7117427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rifabutine in the treatment of mycobacterial infections resistant to rifampicin. Preliminary results. Group for the Study and Treatment of Resistant Mycobacterial Infections (GETIM)].
    Rev Mal Respir; 1989; 6(4):335-42. PubMed ID: 2552547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-resistant and atypical mycobacterial disease. Bacteriology and treatment.
    Lester TW
    Arch Intern Med; 1979 Dec; 139(12):1399-401. PubMed ID: 391173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Case of pulmonary infection with Mycobacterium chelonae in healthy breast-feeding woman].
    Suzuki K; Matsuki A; Saito K; Tanaka Y
    Kekkaku; 2007 Oct; 82(10):759-63. PubMed ID: 18018600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Australian rifampicin trial.
    Proust A; Evans C
    Med J Aust; 1972 Oct; 2(16):861-7. PubMed ID: 4647286
    [No Abstract]   [Full Text] [Related]  

  • 8. Multifocal osteomyelitis due to Mycobacterium szulgai in a patient with chronic lymphocytic leukemia.
    Meyer JJ; Gelman SS
    J Infect; 2008 Feb; 56(2):151-4. PubMed ID: 18199481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary infection caused by Mycobacterium gordonae (M. gordonae) in a healthy middle-aged male].
    Hasegawa T; Tada K; Ishii M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Feb; 30(2):343-6. PubMed ID: 1602666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic results in lung diseases caused by atypical mycobacteria].
    Fischer P; Schilling W
    Z Erkr Atmungsorgane; 1984; 162(1):26-9. PubMed ID: 6202070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pulmonary infection caused by Mycobacterium gordonae in immunocompetent patient].
    Fujita Y; Matsumoto H; Fujikane T; Nakao S; Sasaki N; Takahashi M; Sato K; Takeda A; Yamazaki Y; Tobise K
    Kekkaku; 2000 Apr; 75(4):369-74. PubMed ID: 10808280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of Mycobacterium marinum infections. Use of tetracyclines vs rifampin.
    Donta ST; Smith PW; Levitz RE; Quintiliani R
    Arch Intern Med; 1986 May; 146(5):902-4. PubMed ID: 3963983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathological study of cases with Mycobacterium szulgai infection].
    Iwanaga T; Kishikawa R; Ikeda T; Hirose T; Tsurutani H; Yoshida S
    Kekkaku; 1998 Oct; 73(10):579-84. PubMed ID: 9844345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated cutaneous Mycobacterium marinum infection.
    King AJ; Fairley JA; Rasmussen JE
    Arch Dermatol; 1983 Mar; 119(3):268-70. PubMed ID: 6824363
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of tuberculosis and atypical mycobacterial infections today].
    Jenss H; Jedrychowski A
    Internist (Berl); 1987 Dec; 28(12):796-809. PubMed ID: 3325446
    [No Abstract]   [Full Text] [Related]  

  • 18. Cavitary lung infection caused by Mycobacterium flavescens.
    Casimir MT; Fainstein V; Papadopolous N
    South Med J; 1982 Feb; 75(2):253-4. PubMed ID: 7058379
    [No Abstract]   [Full Text] [Related]  

  • 19. [A study on experimental mycobacterioses provoked by atypical mycobacteria. 2. Combined antituberculous chemotherapy against conventional mice infected intravenously with Mycobacterium intracellulare (author's transl)].
    Kuze F; Lee Y; Maekawa N; Suzuki Y
    Kekkaku; 1979 Sep; 54(9):453-60. PubMed ID: 502152
    [No Abstract]   [Full Text] [Related]  

  • 20. [Investigation on the treatment of infection due to Mycobacterium Kansasii].
    Nakazono T; Sugie T; Ogata H; Mizutani S; Sugita H; Kino T; Wada M
    Kekkaku; 1994 Oct; 69(10):587-92. PubMed ID: 7799569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.